cyclic peptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-11-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analog of alpha-melanocyte-stimulating hormone |
| Primary receptor family | Melanocortin receptors MC1R through MC5R | Binding is not subtype-selective |
| Development period | 1980s | Synthesized during pigmentation and appetite research |
| Regulatory status | Not an approved medicine | No major regulator has authorized human use |
| Related compound | Afamelanotide | Linear analog studied for photoprotection |
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
D-dimer increases with age. It has therefore been suggested to use a cutoff equal to patient's age in years × 10 μg/L (or x 0.056 nmol/L) for patients aged over 50 years for the suspicion of venous thromboembolism (VTE), as it decreases the false positive rate without substantially increasing the false negative rate. An alternative measurement of D-dimer is in fibrinogen equivalent units (FEU). The molecular weight of the fibrinogen molecule is about twice the size of the D-dimer molecule, and therefore 1.0 mcg/mL FEU is equivalent to 0.5 mcg/mL of d-dimer.
Other alien species depicted include antlions, human-sized burrowing insectoids; bullsquids, acid-shooting tentacled predators; and barnacles, ceiling-dwelling amorphous creatures who capture others with their sticky tongue. The series' main recurring symbol is the Greek lambda. It first appears in Half-Life on Freeman's HEV suit and as the namesake of the Lambda Complex responsible for teleporting Freeman to Xen to shut the portal. It reappears in Half-Life 2 as the symbol of the anti-Combine resistance.
Fibronectin type III domain-containing protein 5, the precursor of irisin, is a type I transmembrane glycoprotein that is encoded by the FNDC5 gene. Irisin is a cleaved version of FNDC5, named after the Greek messenger goddess Iris. Fibronectin domain-containing protein 5 is a membrane protein comprising a short cytoplasmic domain, a transmembrane segment, and an ectodomain consisting of a ~100 kDa fibronectin type III (FNIII) domain.
One of the major switches for neuronal activity is the activation of PKs and PPs by elevated intracellular calcium. The degree of activation of the various isoforms of PKs and PPs is controlled by their individual sensitivities to calcium. Furthermore, a wide range of specific inhibitors and targeting partners such as scaffolding, anchoring, and adaptor proteins also contribute to the control of PKs and PPs and recruit them into signalling complexes in neuronal cells. Such signalling complexes typically act to bring PKs and PPs in close proximity with target substrates and signalling molecules as well as enhance their selectivity by restricting accessibility to these substrate proteins. Phosphorylation events, therefore, are controlled not only by the balanced activity of PKs and PPs but also by their restricted localisation. Regulatory subunits and domains serve to restrict specific proteins to particular subcellular compartments and to modulate protein specificity. These regulators are essential for maintaining the coordinated action of signalling cascades, which in neuronal cells include short-term (synaptic) and long-term (nuclear) signalling. These functions are, in part, controlled by allosteric modification by secondary messengers and reversible protein phosphorylation. It is thought that around 30% of known PPs are present in all tissues, with the rest showing some level of tissue restriction.
=== Women bodybuilders === The Cosmeticsurgery.com article They Need Bosoms, too – Women Weight Lifters (2013) reported that women weight-lifters have resorted to breast augmentation surgery to maintain a feminine physique, and so compensate for the loss of breast mass consequent to the increased lean-body mass and decreased body-fat consequent to lifting weights.
Sources: en.wikipedia.org
=== Management === Several precautions can help reduce the risk of developing a sickling crisis. Lifestyle behaviours include maintaining good hydration and avoiding physical stress or exhaustion. Since low oxygen levels can trigger sickling, people with sickle cell disease should avoid high altitudes, such as high mountains or flying in unpressurised aircraft. People with sickle cell disease should avoid alcohol and smoking, as alcohol can cause dehydration and smoking can trigger acute chest syndrome. Stress can also trigger a sickle cell crisis, so relaxation techniques like breathing exercises can help. Pneumococcal infection is a leading cause of death among children with sickle cell disease; penicillin is recommended daily during the first 5 years of life to minimise the risk of infection. Dietary supplementation of folic acid is sometimes recommended, on the basis that it facilitates the creation of new red blood cells and may reduce anaemia. A Cochrane review of its use in 2016 found "the effect of supplementation on anaemia and any symptoms of anaemia remains unclear" due to a lack of medical evidence. People with sickle cell disease are recommended to receive all vaccinations recommended by health authorities to avoid serious infection, which might trigger a sickling crisis. Hydroxyurea was the first approved drug for the treatment of sickle cell disease. It has been shown to decrease the number and severity of attacks and possibly increase survival time.
office Chris Iijima (1969), legal scholar, folksinger Andrei Markovits (1969), professor of comparative politics at the University of Michigan Michel Rosenfeld (1969), constitutional law scholar Mark Rosenzweig (1969), professor of economics at Yale University Steven M. Cohen (1970), sociologist, director of Berman Jewish Policy Archive at NYU's Robert F. Wagner Graduate School of Public Service Sheldon Danziger (1970), political scientist at the University of Michigan Lennard J. Davis (1970), professor of English at the University of Illinois at Chicago, specialist in disability studies John D'Emilio (1970), professor of history and gender studies at the University of Illinois at Chicago; winner of the Bill Whitehead Award in 2013 Samuel Estreicher (1970), professor at the New York University School of Law Peter Grossman (1970), professor of economics at Butler University; columnist, The Indianapolis Star Robert A. Leonard (1970), forensic linguist at Hofstra University and former member of rock band Sha Na Na Michael P. Mezzatesta (1970), art historian, director of the Nasher Museum of Art 1987–2003 Paul Starr (1970), sociologist; co-founder of The American Prospect and winner of the 1984 Pulitzer Prize for General Nonfiction Paul Berman (1971), historian and social critic Philip Nord (1971), historian and professor at Princeton University Steven J.
== Career and research == Biemann was born in Innsbruck, Austria in 1926. He was drafted into the Wehrmacht during the final months of World War II and was sent to aid the divisions fighting against Allied forces then retreating before the Soviet Army on the Eastern Front. Fearing capture, he deserted with a friend to travel back to Innsbruck. Following in the footsteps of his father, he studied pharmacy at the University of Innsbruck where he graduated in 1948. He received his PhD at the University of Innsbruck supervised by Hermann Bretschneider in 1951. He started his work on his habilitation, but instead moved to the MIT in 1955 to work as a postdoctoral fellow in the group of George Büchi. Two years later with the assistance of Büchi, he was offered a faculty position at MIT in the analytical chemistry division where he turned his focus to peptide analysis and sequencing. Before embarking on his new research, however, Biemann decided to buy a mass spectrometer and use it to study peptides instead. He used his background in organic chemistry to modify peptides so that they become volatile and entered the gas phase, making them amenable to electron ionization, the only feasible ionization technique at the time. He partnered on the NASA Viking mission project to Mars which failed to detect organic matter on its the surface in 1976.
== Medical uses == Fixed dose combination of flupentixol and melitracen is indicated for the treatment of anxiety, depression, asthenia, neurasthenia, masked depression, psychosomatic affections accompanied by anxiety and apathy, menopausal depressions, and dysphoria or depression in alcoholics and drug addicts. and is primarily indicated for the following medical uses:
Sources: en.wikipedia.org
== Ion exchange SPE == Ion exchange sorbents separate analytes based on electrostatic interactions between the analyte of interest and the positively or negatively charged groups on the stationary phase. For ion exchange to occur, both the stationary phase and sample must be at a pH where both are charged.
The International Campaign to Abolish Nuclear Weapons (ICAN) is an international alliance of non-governmental organizations committed to the elimination of all nuclear weapons through a binding international treaty - a Nuclear Weapons Convention. ICAN was founded in 2007 by IPPNW (International Physicians for the Prevention of Nuclear War) and other organizations at the Nuclear Non-Proliferation Treaty Conference in Vienna and launched in twelve countries. Today, 468 organizations in 101 countries are involved in the campaign (as of 2017). ICAN was awarded the 2017 Nobel Peace Prize.
== Future perspectives == New generation sequencing may be used to yield a whole genome sequence from cffDNA. This raises ethical questions. However, the utility of the procedure may increase as clear associations between specific genetic variants and disease states are discovered.
Sources: en.wikipedia.org
No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.
Afamelanotide is a linear analog that has received approval in some jurisdictions for a specific photoprotection indication. Melanotan II is cyclic and less selective across melanocortin receptors. The two are related but are not interchangeable in regulatory or clinical terms.
A compound that activates several receptor subtypes may produce effects beyond pigmentation. Selectivity influences which tissues respond and shapes the side-effect profile described in reports. Designing subtype-selective analogs is a stated goal of melanocortin research.
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.